CVE & CISA-KEV Catalog

CVE-2020-27266

MEDIUM
6.5
CVSS v3
NVD

Description

In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, a client-side control vulnerability in the insulin pump and its AnyDana-i and AnyDana-A mobile applications allows physically proximate attackers to bypass user authentication checks via Bluetooth Low Energy.

How to fix

Remediation Available
anydana-a firmwareNVD
Affected:< 3.0Fixed in:3.0CVE-2020-27266derived from NVD
anydana-i firmwareNVD
Affected:< 3.0Fixed in:3.0CVE-2020-27266derived from NVD
diabecare rs firmwareNVD
Affected:< 3.0Fixed in:3.0CVE-2020-27266derived from NVD

TridentStack Control can deploy fixes like this automatically across your Windows, macOS, and Linux fleet. See how it works

Remediation is compiled from vendor and distribution security advisories. Always confirm against the linked source for your exact version and platform.

CVSS v3 Vector

Exploitability

Attack VectorAdjacent
Attack ComplexityLow
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityHigh
IntegrityNone
AvailabilityNone

CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Exploit Intelligence

0.58%probability of exploitation in 30 days
45thpercentile

Moderate risk: more likely to be exploited than 45% of all known CVEs.

References

Third-Party Advisory1

Related Vulnerabilities

Other CWE-603 vulnerabilities, ordered by exploit likelihood. View all

CVESeverityCVSSEPSSExploitedFix
CVE-2022-3218Critical9.873%--
CVE-2020-6988High7.54.0%--
CVE-2017-7909Critical9.82.6%--
CVE-2020-7591High8.81.5%-Fix
CVE-2022-33139Critical9.81.2%--
CVE-2021-43355High7.31.0%-Fix

Common questions

How do I fix CVE-2020-27266?

Published advisories record a fix for 3 affected products. The "How to fix" section on this page lists the fixed version and source advisory for each one, so apply the entry matching what you actually run.

Is CVE-2020-27266 being actively exploited?

Not that we know of. CVE-2020-27266 is not in the CISA Known Exploited Vulnerabilities catalog. Its EPSS score of 0.58% is the estimated probability that it will be exploited in the next 30 days. That is higher than 45% of all scored CVEs.

How severe is CVE-2020-27266?

CVE-2020-27266 has a CVSS v3 base score of 6.5, rated medium. CVSS rates the technical impact if the vulnerability is exploited, not how likely that is, so weigh it alongside the exploit-prediction score when you decide what to patch first.

What does CVE-2020-27266 affect?

Published advisories record a fix for anydana-a firmware (NVD), anydana-i firmware (NVD), diabecare rs firmware (NVD). Only products with a sourced advisory are listed, so treat this as what we can cite rather than a complete inventory.

Embed a live status badge for CVE-2020-27266
CVE-2020-27266 severity badge

Markdown

[![CVE-2020-27266](https://tridentstack.com/cve/badge/CVE-2020-27266.svg)](https://tridentstack.com/cve/CVE-2020-27266)

HTML

<a href="https://tridentstack.com/cve/CVE-2020-27266"><img src="https://tridentstack.com/cve/badge/CVE-2020-27266.svg" alt="CVE-2020-27266"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

See how it worksStart freeThis CVE lookup is free and always will be.

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.